Camlin Fine Sciences Statistics

Total Valuation

Camlin Fine Sciences has a market cap or net worth of INR 19.32 billion. The enterprise value is 25.84 billion.

Market Cap	19.32B
Enterprise Value	25.84B

Important Dates

The last earnings date was Tuesday, November 5, 2024.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

Camlin Fine Sciences has 167.50 million shares outstanding. The number of shares has decreased by -6.44% in one year.

Current Share Class	n/a
Shares Outstanding	167.50M
Shares Change (YoY)	-6.44%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	20.44%
Owned by Institutions (%)	5.72%
Float	80.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	36.62
PS Ratio	1.20
PB Ratio	2.80
P/TBV Ratio	n/a
P/FCF Ratio	19.33
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.92, with an EV/FCF ratio of 25.85.

EV / Earnings	-11.58
EV / Sales	1.61
EV / EBITDA	23.92
EV / EBIT	92.65
EV / FCF	25.85

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 1.15.

Current Ratio	1.20
Quick Ratio	0.47
Debt / Equity	1.15
Debt / EBITDA	7.13
Debt / FCF	7.67
Interest Coverage	0.39

Financial Efficiency

Return on equity (ROE) is -30.71% and return on invested capital (ROIC) is 1.12%.

Return on Equity (ROE)	-30.71%
Return on Assets (ROA)	0.88%
Return on Capital (ROIC)	1.12%
Revenue Per Employee	25.74M
Profits Per Employee	-3.58M
Employee Count	624
Asset Turnover	0.82
Inventory Turnover	1.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.84% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.84%
50-Day Moving Average	105.64
200-Day Moving Average	107.50
Relative Strength Index (RSI)	59.96
Average Volume (20 Days)	77,223

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Camlin Fine Sciences had revenue of INR 16.06 billion and -2.23 billion in losses. Loss per share was -13.38.

Revenue	16.06B
Gross Profit	6.57B
Operating Income	273.85M
Pretax Income	-2.69B
Net Income	-2.23B
EBITDA	980.47M
EBIT	273.85M
Loss Per Share	-13.38

Full Income Statement

Balance Sheet

The company has 905.90 million in cash and 7.67 billion in debt, giving a net cash position of -6.76 billion or -40.38 per share.

Cash & Cash Equivalents	905.90M
Total Debt	7.67B
Net Cash	-6.76B
Net Cash Per Share	-40.38
Equity (Book Value)	6.65B
Book Value Per Share	41.15
Working Capital	1.71B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.61 billion and capital expenditures -609.07 million, giving a free cash flow of 999.68 million.

Operating Cash Flow	1.61B
Capital Expenditures	-609.07M
Free Cash Flow	999.68M
FCF Per Share	5.97

Full Cash Flow Statement

Margins

Gross margin is 40.89%, with operating and profit margins of 1.70% and -13.89%.

Gross Margin	40.89%
Operating Margin	1.70%
Pretax Margin	-16.75%
Profit Margin	-13.89%
EBITDA Margin	6.10%
EBIT Margin	1.70%
FCF Margin	6.22%

Dividends & Yields

Camlin Fine Sciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	6.44%
Shareholder Yield	6.44%
Earnings Yield	-11.60%
FCF Yield	5.17%

Stock Splits

The last stock split was on September 4, 2014. It was a forward split with a ratio of 2.

Last Split Date	Sep 4, 2014
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a